Market revenue in 2024 | USD 4,258.1 million |
Market revenue in 2030 | USD 7,921.9 million |
Growth rate | 11% (CAGR from 2025 to 2030) |
Largest segment | Jet injectors |
Fastest growing segment | Inhaler technology |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Jet injectors, Inhaler technology, Transdermal patch technology, Novel needle-free technologies |
Key market players worldwide | 3M Co, PHARMAJET, Verdict Media Group, Endo Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to needle-free drug delivery devices market will help companies and investors design strategic landscapes.
Jet injectors was the largest segment with a revenue share of 34.56% in 2024. Horizon Databook has segmented the Europe needle-free drug delivery devices market based on jet injectors, inhaler technology, transdermal patch technology, novel needle-free technologies covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe needle-free drug delivery devices market , including forecasts for subscribers. This continent databook contains high-level insights into Europe needle-free drug delivery devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account